Notable Analyst Rating Changes 8/15: SPWR, PCLN, ADSK Upgraded; JNJ, JWN, DNA Downgraded
More News related to ADSK
- Syncromatics Uses Autodesk Inventor to Provide Smart Transit Information for Riders
- Autodesk Unveils Inventor Fusion Technology to Help Engineers Speed Time to Market
- Autodesk Helps Turner Construction Score Big with New Yankee Stadium
- Autodesk Increases Moldflow Performance Two Fold
- Autodesk Leverages NVIDIA GPU Computing to Bolster Moldflow Software Performance
More News related to DNA
- Biogen Idec (BIIB) Announces Decision By Arbitration Panel in Issues with Genentech (DNA)
- Genentech (DNA) Announces Voluntary Withdrawal of Raptiva from the U.S. Market
- FDA ODA Committee Recommends Accelerated Approval of Genentech's (DNA) Avastin for Brain Cancer
- Genentech (DNA) said FDA committee unamiously recommends accelerated approval of Avastin in brain cancer
- Moody's Downgraded Rating On Roche Following Genentech Buyout
More News related to JNJ
- Cougar Biotechnology Announces Successful Completion of Johnson & Johnson's Initial Tender Offer and Commencement of Subsequent Offering Period
- Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
- Unusual 11 Mid-Day Movers 7/2: NAVI, AVNR, ESLR, ELN Higher; DSCO, SEPR, TIVO, ILMN Lower
- Notable Mergers and Acquisitions of the Day 7/2: JNJ/ELN, FCSX/IAAC, LSTR
- Morning Movers 7/2: ELN, QUIK, ESLR Higher; DSCO, LEA, SEPR, ILMN, MANH Lower
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Merrill Lynch upgrades SunPower (Nasdaq: SPWR) from Neutral to Buy, citing valuation and landmark deal with PG&E.
Citi upgrades Priceline.com Inc (Nasdaq: PCLN) from Hold to Buy.
Needham & Co. upgrades Autodesk (Nasdaq: ADSK) from Hold to Buy with a $45 price target.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
UBS downgrades Johnson & Johnson (NYSE: JNJ) from Buy to Neutral, citing generic drop competition for Risperdal and Topamax. The firm raised its price target from $73 to $77.
Merrill Lynch downgrades Nordstrom (NYSE: JWN) from Buy to Neutral with a $31 price target, citing eroding margins.
Citi downgrades Genentech (NYSE: DNA) from Buy to Hold.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Raymond James reinstates coverage on Research In Motion Ltd. (Nasdaq: RIMM) with a Market Perform rating and $140 price target.
Needham & Co. initiates coverage on Under Armour (NYSE: UA) with a Hold rating.
Goldman Sachs resumes coverage on NRG Energy (NYSE: NRG) with a Buy rating and $48 price target.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.55
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
